复发性巨细胞病毒眼前段感染的糖蛋白B基因型与临床特征
这项回顾性研究纳入11例复发性巨细胞病毒(CMV)眼前段感染患者,初诊和复发时房水PCR均可检出CMV DNA,采用巢式多重PCR进行糖蛋白B(gB)基因分型。结果显示复发主要源于初诊优势株再激活,部分老年患者出现新株;复发多发生于抗病毒治疗中断或减量时,超过90%患者同时使用糖皮质激素。
要点
- 复发性CMV眼前段感染主要源于初诊优势株再激活。
- 复发多发生于抗病毒治疗中断或减量时,超过90%患者同时使用糖皮质激素。
- 多数患者出现眼压升高和角膜内皮细胞丢失,部分需手术干预。
核心结论
- 复发性CMV眼前段感染主要源于初诊优势株再激活,提示需要延长抗病毒维持治疗。
- 老年迟发复发患者应考虑新株再感染的可能。
研究设计与样本
- 回顾性研究纳入11例复发性CMV眼前段感染患者,初诊和复发时房水PCR均可检出CMV DNA。
- 对初诊和复发时房水样本采用巢式多重PCR进行gB基因分型。
- 比较优势株再激活组与新株出现组的临床特征和结局。
主要发现
- 初诊时全部11例患者均携带CMV gB1和/或gB3优势株,单独或合并其他次要株。
- 复发时全部患者均显示优势株再激活:2例菌株完全相同,2例保留优势株但丢失部分菌株,7例在优势株基础上获得新菌株。
- 复发发生于抗病毒治疗中断或减量后,超过90%患者同时使用糖皮质激素。
- 多数患者出现眼压升高和角膜内皮细胞丢失,1例需小梁切除术,5例需角膜移植。
- 优势株与新株同时再激活组年龄显著更大(68.3岁 vs 56.3岁,p=0.04),两组临床结局相当。
关键数值与推荐
- 初诊时11例患者均携带gB1和/或gB3优势株。
- 复发时7例在优势株基础上获得新菌株。
- 优势株与新株同时再激活组年龄68.3岁 vs 56.3岁,p=0.04。
临床怎么用
- 复发性CMV眼前段感染患者应考虑延长抗病毒维持治疗以减少优势株再激活。
- 老年迟发复发患者需警惕新株再感染可能。
- 随访中应监测眼压和角膜内皮细胞,必要时行小梁切除术或角膜移植。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To investigate glycoprotein B (gB) genotypes of cytomegalovirus (CMV) in patients with recurrent anterior segment infections and evaluate their clinical characteristics. METHODS: This retrospective study included 11 patients with recurrent CMV anterior segment infection in whom CMV DNA was detectable by aqueous polymerase chain reaction (PCR) at both initial presentation and recurrence. The aqueous humour samples at initial presentation and recurrence were analysed for gB genotyping using a nested multiplex PCR protocol. Clinical features and outcomes were compared between patients with recurrence due to reactivation of initially predominant strains and those with emergence of additional strains. RESULTS: Initially, all 11 patients harboured CMV gB1 and/or gB3 genotypes-predominant strains-either alone or in combination with other minor strains. On recurrence, all patients showed reactivation of predominant strains; two exhibited identical strains, two retained predominant strains but lost some strains and seven acquired new strains in addition to predominant ones. Recurrence occurred following discontinuation or tapering of antiviral therapy, with over 90% of patients receiving corticosteroids concurrently. Most patients developed elevated intraocular pressure and corneal endothelial cell loss; one required trabeculectomy and five underwent corneal transplantation during follow-up. Patients with reactivation involving both predominant and new strains were significantly older (68.3 vs 56.3 years, p=0.04), with comparable clinical outcomes between groups. CONCLUSION: Recurrent CMV anterior segment infection primarily results from reactivation of predominant strains, underscoring the need for extended antiviral maintenance treatment. In elderly patients with late recurrences, reinfection with new strains should be considered.
引用
- Hsu HT, Huang CY, Hwang YS, et al. Glycoprotein B genotypes and clinical features in patients with recurrent cytomegalovirus anterior segment infection. Br J Ophthalmol. 2026. PMID: 42215275. doi:10.1136/bjo-2025-327910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。